Scarica l'app Stockscreener
5.095
3.32%
-0.175
Dopo l'orario di chiusura:
5.15
0.055
+1.08%
Annexon Inc Borsa (ANNX) Ultime notizie
BlackRock, Inc. (ANNX) reports 8.0% beneficial stake in Annexon common stock - Stock Titan
Annexon Inc (ANNX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
ANNX|Annexon Inc|Price:5.130|Chg%:-0.090 - TradingKey
Annexon Inc (ANNX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ANNX|Annexon Inc|Price:5.200|Chg%:+0.070 - TradingKey
Annexon Inc (ANNX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Annexon Inc (ANNX) Institutional Confidence - TradingKey
Annexon Inc (ANNX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Annexon Inc (ANNX) Cash Flow - TradingKey
Annexon Inc (ANNX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Annexon Inc (ANNX) Income Statement - TradingKey
ANNX|Annexon Inc|Price:5.320|Chg%:+0.100 - TradingKey
Annexon Inc (ANNX) Balance Sheet - TradingKey
Breakthrough research in geographic atrophy advanced by Annexon at ASRS2026 - Traders Union
Annexon Inc (ANNX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Annexon Price Target Announced at $3.00/Share by Citizens - Moomoo
ANNX Initiates Coverage On by Citizens -- Rating Set to Market U - GuruFocus
Citizens JMP Initiates Annexon(ANNX.US) With Sell Rating, Announces Target Price $3 - Moomoo
Citizens initiates Annexon stock with underperform on GA trial concerns By Investing.com - Investing.com Canada
H.C. Wainwright Maintains Annexon(ANNX.US) With Buy Rating, Maintains Target Price $14 - Moomoo
H.C. Wainwright reiterates Buy on Annexon stock, $14 target By Investing.com - Investing.com Canada
Weekly Recap: ARCHER II enrollment completed and 335K options to two hires - TradingView
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - Sahm
How Investors Are Reacting To Annexon (ANNX) Phase 3 Tanruprubart Win And Vonaprument Updates - Yahoo Finance
High Growth Tech Stocks To Watch In The US July 2026 - simplywall.st
Annexon grants new hires options for 335,000 shares at USD 6.5 each - Bitget
symbol__ Stock Quote Price and Forecast - CNN
Annexon (ANNX) filer Thomas Wiggans eyes 2,000-share NASDAQ stock sale - Stock Titan
Needham raises Annexon Biosciences stock price target to $25 on trial - Investing.com UK
Needham raises Annexon Biosciences stock price target to $25 on trial By Investing.com - Investing.com South Africa
Needham Maintains Annexon(ANNX.US) With Buy Rating, Raises Target Price to $25 - Moomoo
ANNX Maintained by Needham -- Price Target Raised to $25 - GuruFocus
FMR LLC's Strategic Acquisition of Annexon Inc Shares: A Detailed Analysis - GuruFocus
Annexon (ANNX) Presents Key Findings on Vision Preservation at A - GuruFocus
Annexon to present data on vonaprument for macular degeneration - Investing.com
Annexon to present data on vonaprument for macular degeneration By Investing.com - Investing.com Canada
Annexon to present Phase 2 ARCHER trial vision loss data for vonaprument at ASRS 2026 - Pluang
Annexon to Present Phase 2 ARCHER Baseline Characteristics Associated with Confirmed Best Corrected Visual Acuity 15-Letter Loss in Patients with Geographic Atrophy at ASRS 2026 - GlobeNewswire
Form 144 Annexon For: 14 July By Investing.com - Investing.com Nigeria
Annexon, Inc. SEC Filing (Jul 14, 2026) - Stock Titan
Annexon's tanruprubart shows strong Phase 3 res... - Pluang
Annexon: Perfect Complement To A Speculative Biotech Portfolio (NASDAQ:ANNX) - Seeking Alpha
Cantor Fitzgerald reiterates Overweight on Annexon stock By Investing.com - Investing.com Canada
Price to sales forward of Annexon, Inc. – NASDAQ:ANNX - TradingView
Price to book forward of Annexon, Inc. – NASDAQ:ANNX - TradingView
Enterprise value to revenue forward of Annexon, Inc. – NASDAQ:ANNX - TradingView
Enterprise value to EBITDA forward of Annexon, Inc. – BOATS:ANNX - TradingView
Price to earnings forward of Annexon, Inc. – NASDAQ:ANNX - TradingView
Annexon Inc. (ANNX) Slides 2.36% as Biotech Sector Faces HeadwindsPut Wall - dars.gov.et
Needham Maintains Annexon(ANNX.US) With Buy Rating, Maintains Target Price $11 - Moomoo
Redmile Group (ANNX) reports 9.9% stake; RedCo II Offshore at 5.5% - Stock Titan
FMR LLC reports 11.9% stake in Annexon (NASDAQ: ANNX) - Stock Titan
Does Annexon’s Shift Into Russell Growth Indices Recast Its Core Equity Story for Investors (ANNX)? - simplywall.st
Annexon unveils eight research posters on Guillain-Barré syndrome and tanruprubart at EAN2026 - Traders Union
ANNXAnnexon Inc Options - Finviz
Annexon Inc. (ANNX) Q1 2026 Earnings: EPS Beat Drives Shares Higher Amid Pre-Revenue Pipeline ProgressGross Profit Margin - dars.gov.et
ANNX Q1 2026 Earnings: Narrower-than-Expected Loss Highlights Cost Discipline, but Stock SlipsGuidance Downgrade Alert - dars.gov.et
2.44%
0.02%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):